Clinical trials
Completed Hepatitis B, Chronic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 21 |
| Bristol-Myers Squibb | 11 |
| Assembly Biosciences | 6 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 6 |
| Hoffmann-La Roche | 5 |
| GlaxoSmithKline | 4 |
| Novartis | 3 |
| Novartis Pharmaceuticals | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Aligos Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 74 |
| Hepatitis B | 27 |
| Hepatitis | 11 |
| Hepatitis, Chronic | 4 |
| Liver Diseases | 3 |
| Fibrosis | 2 |
| HIV Infections | 2 |
| Carcinoma, Hepatocellular | 1 |
| Chronic Disease | 1 |
| DNA Virus Infections | 1 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.